504 related articles for article (PubMed ID: 8443746)
21. Intrahepatic chemotherapy with floxuridine, leucovorin and dexamethasone in continuous infusion and mitomycin-C bolus in unresectable hepatic metastases from colorectal cancer: a phase II study.
Bertuccelli M; Falcone A; Campoccia S; Conti M; Brunetti I; Caramella D; Giulianotti PC; Mosca F; Bartolozzi C; Conte PF
Tumori; 1999; 85(6):473-7. PubMed ID: 10774568
[TBL] [Abstract][Full Text] [Related]
22. Folfox4 regimen administered through combined hepatic arterial and systemic infusion for treatment of colorectal cancer with unresectable liver metastases.
Guan M; Chen SC; Ying HY; Zhao L; Li XY; Zhou JF; Shao YJ; Yang XD; Lin Y; Ning XH; Bai CM
Chin Med J (Engl); 2012 Oct; 125(20):3640-5. PubMed ID: 23075717
[TBL] [Abstract][Full Text] [Related]
23. A phase I trial of immediate postoperative intraperitoneal floxuridine and leucovorin plus systemic 5-fluorouracil and levamisole after resection of high risk colon cancer.
Kelsen DP; Saltz L; Cohen AM; Yao TJ; Enker W; Tong W; Tao Y; Bertino JR
Cancer; 1994 Oct; 74(8):2224-33. PubMed ID: 7922973
[TBL] [Abstract][Full Text] [Related]
24. Sequential intrahepatic and systemic fluoropyrimidine-based chemotherapy for metastatic colorectal cancer confined to the liver. A phase II study.
Porta C; Danova M; Accurso S; Tinelli C; Girino M; Riccardi A; Palmeri S
Cancer Chemother Pharmacol; 2001 May; 47(5):423-8. PubMed ID: 11391858
[TBL] [Abstract][Full Text] [Related]
25. Continuous regional treatment with fluoropyrimidines for metastases from colorectal carcinomas: influence of modulation with leucovorin.
Lorenz M; Hottenrott C; Maier P; Reimann M; Inglis R; Encke A
Semin Oncol; 1992 Apr; 19(2 Suppl 3):163-70. PubMed ID: 1532672
[TBL] [Abstract][Full Text] [Related]
26. Phase I clinical and pharmacokinetic study of leucovorin and infusional hepatic arterial fluorouracil.
Kerr DJ; Ledermann JA; McArdle CS; Buckels J; Neoptolemos J; Seymour M; Doughty J; Budden J; Taylor I
J Clin Oncol; 1995 Dec; 13(12):2968-72. PubMed ID: 8523062
[TBL] [Abstract][Full Text] [Related]
27. Comparison of adjuvant systemic chemotherapy with or without hepatic arterial infusional chemotherapy after hepatic resection for metastatic colorectal cancer.
House MG; Kemeny NE; Gönen M; Fong Y; Allen PJ; Paty PB; DeMatteo RP; Blumgart LH; Jarnagin WR; D'Angelica MI
Ann Surg; 2011 Dec; 254(6):851-6. PubMed ID: 21975318
[TBL] [Abstract][Full Text] [Related]
28. Improved hepatic toxicity profile of portal vein adjuvant hepatic infusional chemotherapy.
Faynsod M; Wagman LD; Longmate J; Carroll M; Leong LA
J Clin Oncol; 2005 Aug; 23(22):4876-80. PubMed ID: 16009960
[TBL] [Abstract][Full Text] [Related]
29. Hepatic arterial chemotherapy with oxaliplatin, folinic acid and 5-fluorouracil in pre-treated patients with liver metastases from colorectal cancer.
Del Freo A; Fiorentini G; Sanguinetti F; Muttini MP; Pennucci C; Mambrini A; Pacetti P; Della Seta R; Lombardi M; Torri T; Cantore M
In Vivo; 2006; 20(6A):743-6. PubMed ID: 17203759
[TBL] [Abstract][Full Text] [Related]
30. The value of postoperative hepatic arterial infusion following curative liver resection.
Lorenz M; Staib-Sebler E; Koch B; Gog C; Waldeyer M; Encke A
Anticancer Res; 1997; 17(5B):3825-33. PubMed ID: 9427788
[TBL] [Abstract][Full Text] [Related]
31. Continuous infusion fluorouracil/leucovorin and bolus mitomycin-C as a salvage regimen for patients with advanced colorectal cancer.
Conti JA; Kemeny NE; Saltz LB; André AM; Grossano DD; Bertino JR
Cancer; 1995 Feb; 75(3):769-74. PubMed ID: 7828126
[TBL] [Abstract][Full Text] [Related]
32. Hepatic arterial infusion for unresectable colorectal liver metastases combined or not with systemic chemotherapy.
Pilati P; Mammano E; Mocellin S; Tessari E; Lise M; Nitti D
Anticancer Res; 2009 Oct; 29(10):4139-44. PubMed ID: 19846962
[TBL] [Abstract][Full Text] [Related]
33. Hepatic arterial infusion of oxaliplatin and intravenous LV5FU2 in unresectable liver metastases from colorectal cancer after systemic chemotherapy failure.
Boige V; Malka D; Elias D; Castaing M; De Baere T; Goere D; Dromain C; Pocard M; Ducreux M
Ann Surg Oncol; 2008 Jan; 15(1):219-26. PubMed ID: 17896145
[TBL] [Abstract][Full Text] [Related]
34. Extrahepatic biliary stenoses after hepatic arterial infusion (HAI) of floxuridine (FUdR) for liver metastases from colorectal cancer.
Aldrighetti L; Arru M; Ronzoni M; Salvioni M; Villa E; Ferla G
Hepatogastroenterology; 2001; 48(41):1302-7. PubMed ID: 11677951
[TBL] [Abstract][Full Text] [Related]
35. A pilot study on intensive weekly 24-hour intra-arterial infusion with 5-fluorouracil and folinic acid for colorectal liver metastases.
Lorenz M; Staib-Sebler E; Gog C; Petrowsky H; Köhne CH; Encke A
Oncology; 1998; 55(1):53-8. PubMed ID: 9428376
[TBL] [Abstract][Full Text] [Related]
36. Prevention of extrahepatic disease during intraarterial floxuridine of colorectal liver metastases by simultaneous systemic 5-fluorouracil treatment? A prospective multicenter study.
Lorenz M; Hottenrott C; Inglis R; Kirkowa-Reimann M
Gan To Kagaku Ryoho; 1989 Dec; 16(12):3662-71. PubMed ID: 2531992
[TBL] [Abstract][Full Text] [Related]
37. Hepatic arterial infusion of floxuridine in patients with liver metastases from colorectal carcinoma: long-term results of a prospective randomized trial.
Rougier P; Laplanche A; Huguier M; Hay JM; Ollivier JM; Escat J; Salmon R; Julien M; Roullet Audy JC; Gallot D
J Clin Oncol; 1992 Jul; 10(7):1112-8. PubMed ID: 1296590
[TBL] [Abstract][Full Text] [Related]
38. Systemic irinotecan or regional floxuridine chemotherapy prolongs survival after hepatic cryosurgery in patients with metastatic colon cancer refractory to 5-fluorouracil.
Bilchik AJ; Wood TF; Chawla SP; Rose DM; Chung MH; Stern SS; Foshag LJ; Ramming KP
Clin Colorectal Cancer; 2001 May; 1(1):36-42. PubMed ID: 12445377
[TBL] [Abstract][Full Text] [Related]
39. Alternating systemic and hepatic artery infusion therapy for resected liver metastases from colorectal cancer: a North Central Cancer Treatment Group (NCCTG)/ National Surgical Adjuvant Breast and Bowel Project (NSABP) phase II intergroup trial, N9945/CI-66.
Alberts SR; Roh MS; Mahoney MR; O'Connell MJ; Nagorney DM; Wagman L; Smyrk TC; Weiland TL; Lai LL; Schwarz RE; Molina R; Dentchev T; Bolton JS
J Clin Oncol; 2010 Feb; 28(5):853-8. PubMed ID: 20048179
[TBL] [Abstract][Full Text] [Related]
40. Outcomes of a Phase I/II Trial of Hepatic Arterial Infusion of Oxaliplatin Combined with Intravenous 5-Fluorouracil and l-Leucovorin in Patients with Unresectable Liver Metastases from Colorectal Cancer After Systemic Chemotherapy Failure.
Sato Y; Inaba Y; Ura T; Nishiofuku H; Yamaura H; Kato M; Takahari D; Tanaka T; Muro K
J Gastrointest Cancer; 2018 Jun; 49(2):132-137. PubMed ID: 28058527
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
